Workshop on imaging science development for cancer prevention and preemption

Cancer Biomarkers

Volumn 3, Issue 1, 2007, Pages 1-33

  Kelloff, Gary J ^a   Sullivan, Daniel C ^a   Baker, Houston ^a   Clarke, Lawrence P ^a   Nordstrom, Robert ^a   Tatum, James L ^a   Dorfman, Gary S ^a   Jacobs, Paula ^b   Berg, Christine D ^a   Pomper, Martin G ^c   Birrer, Michael J ^a   Tempero, Margaret ^d   Higley, Howard R ^e   Petty, Brenda Gumbs ^e   Sigman, Caroline C ^e   Maley, Carlo ^f   Sharma, Prateek ^g   Wax, Adam ^h   Ginsberg, Gregory G ⁱ   Dannenberg, Andrew J ^j   Hawk, Ernest T ^a   Messing, Edward M ^k   Grossman, H Barton ^l   Harisinghani, Mukesh ^m   Bigio, Irving J ⁿ   Griebel, Donna ^a   Henson, Donald E ^o   Fabian, Carol J ^p   Ferrara, Katherine ^q   Fantini, Sergio ^r   Schnall, Mitchell D ^s   Zujewski, Jo Anne ^a   Hayes, Wendy ^t   Klein, Eric A ^u   DeMarzo, Angelo ^c   Ocak, Iclal ^a   Ketterling, Jeffrey A ^v   Tempany, Clare ^w   Shtern, Faina ^x   Parnes, Howard L ^a   Gomez, Jorge ^a   Srivastava, Sudhir ^a   Szabo, Eva ^a   Lam, Stephen ^y   Seibel, Eric J ^z   Massion, Pierre ^aa   McLennan, Geoffrey ^ab   Cleary, Kevin ^ac   Suh, Robert ^ad   Burt, Randall W ^ae   Pfeiffer, Ruth M ^a   Hoffman, John M ^af   Roy, Hemant K ^ag   Wang, Thomas ^ah   Limburg, Paul J ⁱ   El Deiry, Wafik S ^l   Papadimitrakopoulou, Vali ^l   Hittelman, Walter N ^ai   MacAulay, Calum ^aj   Veltri, Robert W ^a   Solomonzz, Diane ^a   Jeronimo, Jose ^ak   Richards Kortum, Rebecca ^al   Johnson, Karen A ^am   Viner, Jaye L ^a   Stratton, Steven P ^am   Rajadhyaksha, Milind ^an   Dhawan, Atam ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CCS Associates   (United States)

^f WISTAR INSTITUTE   (United States)

^g UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^h Duke University   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j WEILL CORNELL MEDICAL COLLEGE   (United States)

^k UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ BOSTON UNIVERSITY   (United States)

^o GEORGE WASHINGTON UNIVERSITY   (United States)

^p UNIVERSITY OF KANSAS CANCER CENTER   (United States)

^q University of California   (United States)

^r Tufts University   (United States)

^s UNIVERSITY OF PENNSYLVANIA   (United States)

^t NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^u LERNER RESEARCH INSTITUTE   (United States)

^v RIVERSIDE RESEARCH INSTITUTE   (United States)

^w BRIGHAM AND WOMEN S HOSPITAL   (United States)

^x Department of Radiology   (United States)

^y UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^z UNIVERSITY OF WASHINGTON   (United States)

^aa VANDERBILT INGRAM CANCER CENTER   (United States)

^ab UNIVERSITY OF IOWA HEALTH CARE   (United States)

^ac GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^ad UNIVERSITY OF CALIFORNIA   (United States)

^ae UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^af EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^ag STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ah Mayo Clinic   (United States)

^ai BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^aj JOHNS HOPKINS HOSPITAL   (United States)

^ak UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^al UNIVERSITY OF ARIZONA   (United States)

^am MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^an NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; ANTIMITOTIC AGENT; ARZOXIFENE; BCG VACCINE; BETA CAROTENE; BEVACIZUMAB; CALCIUM; CAPECITABINE; CETUXIMAB; DICLOFENAC; EPIGALLOCATECHIN GALLATE; FLUOROURACIL; FOLINIC ACID; IMIQUIMOD; IMMUNOMODULATING AGENT; IRINOTECAN; LETROZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OXALIPLATIN; PACLITAXEL; PHOTOFRIN; PROTON PUMP INHIBITOR; RESIQUIMOD; RETINOID; SELENIUM; TAMOXIFEN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNINDEXED DRUG;

ACTINIC KERATOSIS; ADJUVANT THERAPY; ARTICLE; BARRETT ESOPHAGUS; BLADDER CANCER; BREAST CANCER; BREAST TUMOR; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CATHETER ABLATION; CHEMOPROPHYLAXIS; CHROMOSOMAL INSTABILITY; CLINICAL TRIAL; COLON CANCER; COLONOSCOPY; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CRYOTHERAPY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG MEGADOSE; DRUG UPTAKE; EARLY CANCER; EARLY DIAGNOSIS; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EPILUMINESCENCE MICROSCOPY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; FLUORESCENCE MICROSCOPY; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENOMIC INSTABILITY; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; LEUKOPLAKIA; LIGHT SCATTERING; LOW DRUG DOSE; LUNG CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; MAMMOGRAPHY; MICROBUBBLE; MOLECULAR IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OVARY CANCER; PANCREAS CANCER; PAPANICOLAOU TEST; PHAGE DISPLAY; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SKIN CANCER; THREE DIMENSIONAL IMAGING; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CANCER; WART VIRUS;

EID: 34547105075     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/cbm-2007-3101     Document Type: Article

References (230)

1. W. Abramovits and L.C. Stevenson, Changing paradigms in dermatology: New ways to examine the skin using noninvasive imaging methods, Clin Dermatol 21 (2003), 353-358.
2. A.J. Aguirre, N. Bardeesy, M. Sinha, L. Lopez, D.A. Tuveson, J. Homer, M.S. Redston and R.A. DePinho, Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma, Genes Dev 17 (2003), 3112-3126.
3. N.A. Ahmad, M.L. Kochman, W.B. Long, E.E. Furth and G.G. Ginsberg, Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases, Gastrointest Endosc 55 (2002), 390-396.
4. J.F. Aitken, M. Janda, M. Elwood, P.H. Youl, I.T. Ring and J.B. Lowe, Clinical outcomes from skill screening clinics within a community-based melanoma screening program, J Am Acad Dermatol 54 (2006), 105-114.
5. S.C. American, Cancer Facts and Figures 2006, American Cancer Society, Atlanta, 2006.
6. N. Arber, C.J. Eagle, J. Spicak, I. Racz, P. Dire, J. Hajer, M. Zavoral, M.J. Lechuga, P. Gerletti, J. Tang, R.B. Rosenstein, K. Macdonald, P. Bhadra, R. Fowler, J. Wittes, A.G. Zauber, S.D. Solomon and B. Levin, Celecoxib for the prevention of colorectal adenomatous polyps, N Engl J Med 355 (2006), 885-895.
7. N. Arslan, F. Dehdashti and B.A. Siegel, FDG uptake in colonic villous adenomas, Ann Nucl Med 19 (2005), 331-334.
8. W. Atkin and J.P. Martin, Stool DNA-based colorectal cancer detection: finding the needle in the haystack, J Natl Cancer Inst 93 (2001), 798-799.
9. M. Babjuk, V. Soukup, R. Petrik, M. Jirsa and J. Dvoracek, 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer, BJU Int 96 (2005), 798-802.
10. J. Bartek and J. Lukas, Chk1 and Chk2 kinases in checkpoint control and cancer, Cancer Cell 3 (2003), 421-429.
11. P.H. Bartels, J. Ranger-Moore, M.S. Stratton, P. Bozzo, J. Einspahr, Y. Liu, D. Thompson and D.S. Alberts, Statistical analysis of chemopreventive efficacy of vitamin A in sun-exposed, normal skin, Anal Quant Cytol Histol 24 (2002), 185-197.
12. J.K. Barton, K.W. Gossage, W. Xu, J.R. Ranger-Moore, K. Saboda, C.A. Brooks, L.D. Duckett, S.J. Salasche, J.A. Warneke and D.S. Alberts, Investigating sun-damaged skin and actinic keratosis with optical coherence tomography: A pilot study, Technol Cancer Res Treat 2 (2003), 525-535.
13. I. Bedrosian, J. Schlencker, F.R. Spitz, S.G. Orel, D.L. Fraker, L.S. Callans, M. Schnall, C. Reynolds and B.J. Czerniecki, Magnetic resonance imaging-guided biopsy of mammographically and clinically occult breast lesions, Ann Surg Oncol 9 (2002), 457-461.
14. C. Bernstein, H. Bernstein, H. Garewal, P. Dinning, R. Jabi, R.E. Sampliner, M.K. McCuskey, M. Panda, D.J. Roe, L. L'Heureux and C. Payne, A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies, Cancer Res 59 (1999), 2353-2357.
15. M.M. Bertsgnolli, C.J. Eagle, A.G. Zauber, M. Redston, S.D. Solomon, K. Kim, J. Tang, R.B. Rosenstein, J. Wittes, D. Corle, T.M. Hess, G.M. Woloj, F. Boisserie, W.F. Anderson, J.L. Viner, D. Bagheri, J. Burn, D.C. Chung, T. Dewar, T.R. Foley, N. Hoffman, F. Macrae, R.E. Pruitt, J.R. Saltzman, B. Salzberg, T. Sylwestrowicz, G.B. Gordon and E.T. Hawk, Celecoxib for the prevention of sporadic colorectal adenomas, N Engl J Med 355 (2006), 873-884.
16. C. Bettegowda, C.A. Foss, I. Cheong, Y. Wang, L. Diaz, N. Agrawal, J. Fox, J. Dick, L.H. Dang, S. Zhou, K.W. Kinzler, B. Vogelstein and M.G. Pomper, Imaging bacterial infections with radiolabeled 1-(2′-deoxy-2′-fluoro-beta-D-arabinofuranosyl)-5-iodouracil, Proc Natl Acad Sci USA 102 (2005), 1145-1150.
17. A.C. Borczuk, L. Shah, G.D. Pearson, K.L. Walter, L. Wang, J.H. Austin, R.A. Friedman and C.A. Powell, Molecular signatures in biopsy specimens of lung cancer, Am J Respir Crit Care Med 170 (2004), 167-174.
18. S. Bota, J.B. Auliac, C. Paris, J. Metayer, R. Sesboue, G. Nouvet and L. Thiberville, Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy, Am J Respir Crit Care Med 164 (2001), 1688-1693.
19. R.S. Bresalier, J.C. Byrd, D. Testier, J. Lebel, J. Koomen, D. Hawke, E. Half, K.F. Liu and N. Mazurek, A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer, Gastroenterology 127 (2004), 741-748.
20. R.H. Breuer, A. Pasic, E.F. Smit, E. van Vliet, A. Vonk Noordegraaf, E.J. Risse, P.E. Postmus and T.G. Sutedja, The natural course of preneoplastic lesions in bronchial epithelium, Clin Cancer Res 11 (2005), 537-543.
21. L.M. Brown and S.S. Devesa, Epidemiologic trends in esophageal and gastric cancer in the United States, Surg Oncol Clin N Am 11 (2002), 235-256.
22. K.J. Busam, C. Charles, G. Lee and A.C. Halpern, Morphologic features of melanocytes, pigmented keratinocytes, and melanophages by in vivo confocal scanning laser microscopy, Mod Pathol 14 (2001), 862-868.
23. K.J. Busam, C. Charles, C.M. Lohmann, A. Marghoob, M. Goldgeier and A.C. Halpern, Detection of intraepidermal malignant melanoma in vivo by confocal scanning laser microscopy, Melanoma Res 12 (2002), 349-355.
24. N.S. Buttar, K.K. Wang, T.J. Sebo, D.M. Riehle, K.K. Krishnadath, L.S. Lutzke, M.A. Anderson, T.M. Petterson and L.J. Burgart, Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma, Gastroenterology 120 (2001), 1630-1639.
25. N.J. Camp and M.L. Slattery, Classification tree analysis: A statistical tool to investigate risk factor interactions with an example for colon cancer (United States), Cancer Causes Control 13 (2002), 813-823.
26. L.A. Cannon-Albright, M.H. Skolnick, D.T. Bishop, R.G. Lee and R.W. Burt, Common inheritance of susceptibility to colonic adenomatons polyps and associated colorectal cancers, N Engl J Med 319 (1988), 533-537.
27. P. Carli, V. de Giorgi, A. Chiarugi, P. Nardini, M.A. Weinstock, E. Crocetti, M. Stante and B. Giannotti, Addition of dermoscopy to conventional naked-eye examination in melanoma screening: A randomized study, J Am Acad Dermatol 50 (2004), 683-689.
28. J.A. Chappel, M. He and A.S. Kang, Modulation of antibody display on M13 filamentous phage, J Immunol Methods 221 (1998), 25-34.
29. L.C. Chen, C.Y. Hao, Y.S. Chiu, P. Wong, J.S. Melnick, M. Brotman, J. Moretto, F. Mendes, A.P. Smith, J.L. Bennington, D. Moore and N.M. Lee, Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients, Cancer Res 64 (2004), 3694-3700.
30. A.O. Coates, J.D. Potter, B.J. Caan, S.L. Edwards and M.L. Slattery, Eating frequency and the risk of colon cancer, Nutr Cancer 43 (2002), 121-126.
31. L.C. Costello, R.B. Franklin and P. Narayan, Citrate in the diagnosis of prostate cancer, Prostate 38 (1999), 237-245.
32. M. Cruz, K. Tsuda, Y. Narumi, Y. Koroiwa, T. Nose, Y. Kojima, A. Okuyama, S. Takahashi, K. Aozasa, J.O. Barentsz and H. Nakamura, Characterization of low-intensity lesions in the peripheral zone of prostate on pre-biopsy endorectal coil MR imaging, Eur Radiol 12 (2002), 357-365.
33. A.V. D'Amico, R. Cormack, C.M. Tempany, S. Kumar, G. Topulos, H.M. Kooy and C.N. Coleman, Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer, Int J Radiat Oncol Biol Phys 42 (1998), 507-515.
34. A.M. DeMarzo, W.G. Nelson, W.B. Isaacs and J.I. Epstein, Pathological and molecular aspects of prostate cancer, Lancet 361 (2003 , 955-964.
35. W.M. Deserno, M.G. Harisinghani, M. Taupitz, G.J. Jager, J.A. Witjes, P.F. Mulders, C.A. Hulsbergen van de Kaa, D. Kaufmann and J.O. Barentsz, Urinary bladder cancer: Preoperative nodal staging with ferumoxtran-10-enhanced MR imaging, Radiology 233 (2004), 449-456.
36. R.A. DiTullio, Jr., T.A. Mochan, M. Venere, J. Bartkova, M. Sehested, J. Bartek and T.D. Halazonetis, 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer, Nat Cell Biol 4 (2002), 998-1002.
37. J.P. Drenth, F.M. Nagengast and W.J. Oyen, Evaluation of (pre-)malignant colonic abnormalities: Endoscopic validation of FDG-PET findings, Eur J Nucl Med 28 (2001), 1766-1769.
38. W. Drexler, Ultrahigh-resolution optical coherence tomography, J Biomed Opt 9 (2004), 47-74.
39. M. Durst, D. Glitz, A. Schneider and H. zur Hausen, Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization, Virology 189 (1992), 132-140.
40. W.S. El-Deity, C.C. Sigman and G.J. Kelloff, Imaging and oncologic drug development, J Clin Oncol 24 (2006), 3261-3273.
41. T. Endo, T. Awakawa, H. Takahashi, Y. Arimura, F. Itoh, K. Yamashita, S. Sasaki, H. Yamamoto, X. Tang and K. Imai, Classification of Barrett's epithelium by magnifying endoscopy, Gastrointest Endosc 55 (2002), 641-647.
42. C.J. Fabian, B.F. Kimler, J.R. Anderson, C. Chamberlain, M.S. Mayo, C.M. Zalles, J.A. O'Shaughnessy, H.T. Lynch, K.A. Johnson and D. Browne, Phase II breast cancer chemoprevention trial of the third generation selective estrogen receptor modulator arzoxifene, J Clin Oncol 24 (Suppl) (2006), abst. No. 1001.
43. C.J. Fabian, B.F. Kimler, C.M. Zalles, J.R. Klemp, S. Kamel, S. Zeiger and M.S. Mayo, Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gall risk model, J Natl Cancer Inst 92 (2000), 1217-1227.
44. E.J. Feleppa, R.D. Ennis, P.B. Schiff, C.S. Wuu, A. Kalisz, J. Ketterling, S. Urban, T. Liu, W.R. Fair, C.R. Porter and J.R. Gillespie, Ultrasonic spectrum-analysis and neural-network classification as a basis for ultrasonic imaging to target brachytherapy of prostate cancer, Brachytherapy 1 (2002), 48-53.
45. W. Feng, W. Liu, C. Li, Z. Li, R. Li, F. Liu, B. Zhai, J. Shi and G. Shi, Percutaneous microwave coagulation therapy for long cancer, Zhonghua Zhong Liu Za Zhi 24 (2002), 388-390.
46. J.S. Ferguson and G. McLennan, Virtual bronchoscopy, Proc Am Thorac Soc 2 (2005), 488-491, 504-485.
47. K.W. Ferrara, C.R. Merritt, P.N. Burns, F.S. Foster, R.F. Mattrey and S.A. Wickline, Evaluation of tumor angiogenesis with US: Imaging, Doppler, and contrast agents, Acad Radiol 7 (2000), 824-839.
48. T. Filbeck, U. Pichlmeier, R. Knuechel, W.F. Wieland and W. Roessler, Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors, J Urol 168 (2002), 67-71.
49. C.A. Foss, R.C. Mease, H. Fan, Y. Wang, H.T. Ravert, R.F. Dannals, R.T. Olszewski, W.D. Heston, A.P. Kozikowski and M.G. Pomper, Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer, Clin Cancer Res 11 (2005), 4022-4028.
50. A.N. Freedman, D. Seminara, M.H. Gaff, P. Hartge, G.A. Colditz, R. Ballard-Barbash and P.M. Pfeiffer, Cancer risk prediction models: A workshop on development, evaluation, and application, J Natl Cancer Inst 97 (2005), 715-723.
51. S.J. Freemantle, K.H. Dragnev and E. Dmitrovsky, The retinoic acid paradox in cancer chemoprevention, J Natl Cancer Inst 98 (2006), 426-427.
52. J.G. Fujimoto, Optical coherence tomography for ultrahigh resolution in vivo imaging, Nat Biotechnol 21 (2003), 1361-1367.
53. M.H. Gail, L.A. Brinton, D.P. Byar, D.K. Corle, S.B. Green, C. Schairer and J.J. Mulvihill, Projecting individualized probabilities of developing breast cancer for white females who are being examined annually, J Natl Cancer Inst 81 (1989), 1879-1886.
54. K. Garber, Energy deregulation: Licensing tumors to grow, Science 312 (2006), 1158-1159.
55. A. Gelet, J.Y. Chapelon, R. Bouvier, C. Pangaud and Y. Lasne, Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: Preliminary results, J Urol 161 (1999), 156-162.
56. A. Gergar, S. Koller, T. Kern, C. Massone, K. Steiger, E. Richtig, H. Kerl and J. Smolle, Diagnostic applicability of in vivo confocal laser scanning microscopy in melanocytic skin tumors, J Invest Dermatol 124 (2005), 493-498.
57. L.B. Gerson, K. Shetler and G. Triadafilopoulos, Prevalence of Barrett's esophagus in asymptomatic individuals, Gastroenterology 123 (2002), 461-467.
58. D. Gianfelice, A. Khiat, Y. Boulanger, M. Amara and A. Belblidia, Feasibility of magnetic resonance imaging-guided focused ultrasound surgery as an adjunct to tamoxifen therapy in high-risk surgical patients with breast carcinoma, J Vasc Interv Radiol 14 (2003), 1275-1282.
59. S.N. Goldberg, J. Bonn, G. Dodd, D. Dupuy, J.H. Gesehwind, M. Hicks, K.M. Heme, F.T. Lee, C.A. Lewis, R.A. Lencioni, R.A. Omary, J.H. Rundback, S. Silverman and G.S. Dorfman, Society of Interventional Radiology Interventional Ontology Task Force: Interventional oncology research vision statement and critical assessment of the state of research affairs, J Vasc Interv Radiol 16 (2005), 1287-1294.
60. M.I. Golding, D.B. Doman and H.J. Goldberg, Take your Pill(Cam): It might save your life, Gastrointest Endosc 62 (2005), 196-198.
61. S. Gonzalez, K. Swindells, M. Rajadhyaksha and A. Torres, Changing paradigms in dermatology: Confocal microscopy in clinical and surgical dermatology, Clin Dermatol 21 (2003), 359-369.
62. V.G. Gorgoulis, L.V. Vassiliou, P. Karakaidos, P. Zacharatos, A. Kotsinas, T. Liloglou, M. Venere, R.A. Ditullio, Jr., N.G. Kastrinakis, B. Levy, D. Kletsas, A. Yoneta, M. Herlyn, C. Kittas and T.D. Halazonetis, Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions, Nature 434 (2005), 907-913.
63. L. Gotz, S.H. Heywang-Kobrunner, O. Schutz and H. Siebold, Optical mammography in preoperative patients, Aktuelle Radiol 8 (1998), 31-33.
64. C.A. Caanville and P.A. Dennis, An overview of lung cancer genomics and proteomics, Am J Respir Cell Mol Biol 32 (2005), 169-176.
65. M.H. Greene, Genetics of cutaneous melanoma and nevi, Mayo Clin Proc 72 (1997), 467-474.
66. J. Gu, H.B. Grossman, C.P. Dinney and X. Wu, The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence, Pharmacogenomics 6 (2005), 575-584.
67. C.H. Halbert, H. Lynch, J. Lynch, D. Main, S. Kucharski, A.K. Rustgi and C. Lerman, Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations, Arch Intern Med 164 (2004), 1881-1887.
68. W. Harms, R. Krempien, C. Grehn, F. Hensley, J. Debus and H.D. Becker, Electromagnetically navigated brachytherapy as a new treatment option for peripheral pulmonary tumors, Strahlenther Onkol 182 (2006), 108-111.
69. L.J. Havrilesky, S.L. Kulusingam, D.B. Matchar and E.R. Myers, FDG-PET for management of cervical and ovarian cancer, Gynecol Oncol 97 (2005), 183-191.
70. R.B. Hayes, A. Sigurdson, L. Moore, U. Peters, W.Y. Huang, P. Piusky, D. Reding, E.P. Gelmann, N. Rothman, R.M. Pfeiffer, R.N. Hoover and C.D. Berg, Methods for etiologic and early marker investigations in the PLCO trial, Mutat Res 592 (2005), 147-154.
71. P.M. Heavey, D. McKenna and I.R. Rowland, Colorectal cancer and the relationship between genes and the environment, Nutr Cancer 48 (2004), 124-141.
72. E. Heffer, V. Pera, O. Schutz, H. Siebold and S. Fantini, Near-infrared imaging of the human breast: Complementing hemoglobin concentration maps with oxygenation images, J Biomed Opt 9 (2004), 1152-1160.
73. H.W. Herr, B.H. Bochner, G. Dalbagni, S.M. Donat, V.E. Reuter and D.F. Bajorin, Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer, J Urol 167 (2002), 1295-1298.
74. S.R. Hingorani, E.F. Petricoin, A. Maitra, V. Rajapakse, C. King, M.A. Jacobetz, S. Ross, T.P. Conrads, T.D. Veenstra, B.A. Hitt, Y. Kawaguchi, D. Johann, L.A. Liotta, H.C. Crawford, M.E. Putt, T. Jacks, C.V. Wright, R.H. Hruban, A.M. Lowy and D.A. Tuveson, Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse, Cancer Cell 4 (2003), 437-450.
75. W.K. Hirota, T.M. Loughney, D.J. Lazas, C.L. Maydonovitch, V. Rholl and R.K. Wong, Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data, Gastroenterology 116 (1999), 277-285.
76. W.N. Hittelman, Genetic instability in epithelial tissues at risk for cancer, Ann N Y Acad Sci 952 (2001), 1-12.
77. C.G. Hobbs, J.A. Sterne, M. Bailey, R.S. Heyderman, M.A. Birchall and S.J. Thomas, Human papillomavirus and head and neck cancer:, a systematic review and meta-analysis, Clin Otolaryngol 31 (2006), 259-266.
78. R. Holland, S.H. Veling, M. Mravunac and J.H. Hendriks, Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery, Cancer 56 (1985), 979-990.
79. H. Hoshino, K. Shibuya, M. Chiyo, A. Iyoda, S. Yoshida, Y. Sekine, T. Iizasa, Y. Saitoh, M. Baba, K. Hiroshima, H. Ohwada and T. Fujisuwa, Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy, Lung Cancer 46 (2004), 187-196.
80. R.H. Hruban, N.V. Adsay, J. Albores-Saavedra, C. Compton, E.S. Garrett, S.N. Goodman, S.E. Kern, D.S. Klimstra, G. Kloppel, D.S. Longnecker, J. Luttges and G.J. Offerhaus, Pancreatic intraepithelial neoplasia: A new nomenclature and classification system for pancreatic duct lesions, Am J Surg Pathol 25 (2001), 579-586.
81. J.G. Izzo, V.A. Papadimitrakopoulou, D.D. Liu, P.L. den Hollander, I.M. Babenko, J. Keck, A.K. El-Naggar, D.M. Shin, J.J. Lee, W.K. Hong and W.N. Hittelman, Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer, J Natl Cancer Inst 95 (2003), 198-205.
82. I.J. Jacobs, S.J. Skates, N. MacDonald, U. Menon, A.N. Rosenthal, A.P. Davies, R. Woolas, A.R. Jeyarajah, K. Sibley, D.G. Lowe and D.H. Oram, Screening for ovarian cancer: A pilot randomised controlled trial, Lancet 353 (1999), 1207-1210.
83. M. Jeanmart, S. Lantuejoul, F. Fievet, D. Moro, N. Sturm, C. Brambilla and E. Brambilla, Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer, Clin Cancer Res 9 (2003), 2195-2203.
84. A. Jemal, S.S. Devesa, P. Hartge and M.A. Tucker, Recent trends in cutaneous melanoma incidence among whites in the United States, J Natl Cancer Inst 93 (2001), 678-683.
85. D. Jocham, F. Witjes, S. Wagner, B. Zeylomaker, J. van Moorselaar, M.O. Grimm, R. Muschter, G. Popken, F. Konig, R. Knuchel and K.H. Korth, Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: A prospective, phase III multicenter study, J Urol 174 (2005), 862-866; discussion 866.
86. Y. Kaji, J. Kurhanewicz, H. Hricak, D.L. Sokolov, L.R. Huang, S.J. Nelson and D.B. Vigneron, Localizing prostate cancer in the presence of postbiopsy changes on MR images: Role of proton MR spectroscopic imaging, Radiology 206 (1998), 785-790.
87. M. Kara, R.S. DaCosta, B.C. Wilson, N.E. Marcon and J. Bergman, Autofluorescence-based detection of early neoplasia in patients with Barrett's esophagus, Dig Dis 22 (2004), 134-141.
88. S.S. Karhadkar, G.S. Bova, N. Abdallah, S. Dhara, D. Gardner, A. Maitra, J.T. Isaacs, D.M. Berman and P.A. Beachy, Hedgehog signalling in prostate regeneration, neoplasia and metastasis, Nature 431 (2004), 707-712.
89. M.B. Kastan and J. Bartek, Cell-cycle checkpoints and cancer, Nature 432 (2004), 316-323.
90. M. Kawamura, Y. Izumi, N. Tsukada, K. Asakura, H. Sugiura, H. Yashiro, K. Nakano, S. Nakatsuka, S. Kuribayashi and K. Kobayashi, Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates, J Thorac Cardiovasc Surg 131 (2006), 1007-1013.
91. G.J. Kelloff, K.A. Krohn, S.M. Larson, R. Weissleder, D.A. Mankoff, J.M. Hoffman, J.M. Link, K.Z. Guytun, W.C. Eckelman, H.I. Scher, J. O'Shanghnessy, B.D. Cheson, C.C. Sigman, J.L. Tatum, G.Q. Mills, D.C. Sullivan and J. Woodcock, The progress and promise of molecular imaging probes in oncologic drug development, Clin Cancer Res 11 (2005), 7967-7985.
92. G.J. Kelloff, S.M. Lippman, A.J. Dannenberg, C.C. Sigman, H.L. Pearce, B.J. Reid, E. Szabo, V.C. Jordan, M.R. Spitz, G.B. Mills, V.A. Papadimitrakopoulou, R. Lotan, B.B. Aggarwal, R.S. Bresalier, J. Kim, B. Arun, K.H. Lu, M.E. Thomas, H.E. Rhodes, M.A. Brewer, M. Follen, D.M. Shin, H.L. Parnes, J.M. Siegfried, A.A. Evans, W.J. Blot, W.H. Chow, P.L. Blount, C.C. Maley, K.K. Wang, S. Lam, J.J. Lee, S.M. Dubinett, P.F. Engstrom, F.L. Meyskens, Jr., J. O'Shaughnessy, E.T. Hawk, B. Levin, W.G. Nelson and W.K. Hong, Progress in chemoprevention drug development: The promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer - a plan to move forward, Clin Cancer Res 12 (2006), 3661-3697.
93. G.J. Kelloff, C.C. Sigman, K.M. Johnson, C.W. Boone, P. Greenwald, J.A. Crowell, E.T. Hawk and L.A. Doody, Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer, Cancer Epidemiol Biomarkers Prev 9 (2000), 127-137.
94. A. Khiat, D. Gianfelice, M. Amara and Y. Boulanger, Influence of post-treatment delay on the evaluation of the response to focused ultrasound surgery of breast cancer by dynamic contrast enhanced MRI, Br J Radiol 79 (2006), 308-314.
95. D.O. Kiesewetter, M.R. Klibourn, S.W. Landvatter, D.F. Heiman, J.A. Katzenellenbogen and M.J. Welch, Preparation of four fluorine- 18-labeled estrogens and their selective uptakes in target tissues of immature rats, J Nucl Med 25 (1984), 1212-1221.
96. Y.L. Kim, Y. Liu, R.K. Wali, H.K. Roy, M.J. Goldberg, A.K. Kromin, K. Chen and V. Backman, Simultaneous measurement of angular and spectral properties of light scattering for characterization of tissue microarchitecture and its alteration in early precancer, IEEE J Selected Topics Quantum Electron 9 (2003), 243-256.
97. B.F. Kimler, G. Ursin, C.J. Fabian, J.R. Anderson, C. Chamberlain, M.S. Mayo, J.A. O'Shaughnessy, H.T. Lynch, K.A. Johnson and D. Browne, Effect of the third generation selective estrogen receptor modulator arzoxifene on mammographic breast density, J Clin Oncol 24 (Suppl) (2006), abst. No. 562.
98. K. Kinkel, H. Hricak, Y. Lu, K. Tsuda and R.A. Filly, US characterization of ovarian masses: A meta-analysis, Radiology 217 (2000), 803-811.
99. E.A. Klein and C.D. Zippe, Transrectal ultrasound guided prostate biopsy - defining a new standard, J Urol 163 (2000), 179-180.
100. J.S. Klein and M.A. Zarka, Transthoracic needle biopsy, Radiol Clin North Am 38 (2000), 235-266, vii.
101. M. Kriege, C.T. Brekelmans, C. Boetes, P.E. Besnard, H.M. Zonderland, LM. Obdeijn, R.A. Manoliu, T. Kok, H. Peterse, M.M. Tilanus-Linthorst, S.H. Muller, S. Meijer, J.C. Oosterwijk, L.V. Beex, R.A. Tollenaar, H.J. de Koning, E.J. Rutgels and J.G. Klijn, Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition, N Engl J Med 351 (2004), 427-437.
102. A.B. Kurtz, J.V. Tsimikas, C.M. Tempany, U.M. Hamper, P.H. Arger, R.L. Bree, R.J. Wechsler, I.R. Francis, J.E. Kuhlman, E.S. Siegelman, D.G. Mitchell, S.G. Silverman, D.L. Brown, S. Sheth, B.G. Coleman, J.H. Ellis, R.J. Kurman, D.J. Caudry and B.J. McNeil, Diagnosis and staging of ovarian cancer: Comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis - report of the Radiology Diagnostic Oncology Group, Radiology 212 (1999), 19-27.
103. U. Ladabaum and K. Song, Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand, Gastroenterology 129 (2005), 1151-1162.
104. S. Lam, C. MacAulay, J.C. Le Riche, Y. Dyachkova, A. Coldman, M. Guillaud, E. Hawk, M.O. Christen and A.F. Gazdar, A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia, J Natl Cancer Inst 94 (2002), 1001-1009.
105. P.M. Lane, T. Gilhuly, P. Whitehead, H. Zeng, C.F. Poh, S. Ng, P.M. Williams, L. Zhang, M.P. Rosin and C.E. MacAulay, Simple device for the direct visualization of oral-cavity tissue fluorescence, J Biomed Opt 11 (2006), 024006.
106. R.G. Langley, M. Rajadhyskaha, P.J. Dwyer, A.J. Sober, T.J. Flotte and R.R. Anderson, Confocal scanning laser microscopy of benign and malignant melanocylic skin lesions in vivo, J Am Acad Dermatol 45 (2001), 365-376.
107. S.M. Larson, M. Morris, I. Gunther, B. Beattie, J.L. Humm, T.A. Akhurst, R.D. Finn, Y. Erdi, K. Pentlow, J. Dyke, O. Squire, W. Bornmann, T. McCarthy, M. Welch and H. Scher, Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer, J Nucl Med 45 (2004), 366-373.
108. M.O. Leach, C.R. Boggis, A.K. Dixon, D.F. Easton, R.A. Eeles, D.G. Evans, F.J. Gilbert, I. Griebsch, R.J. Hoff, P. Kessar, S.R. Lakhani, S.M. Moss, A. Nerurkar, A.R. Padhani, L.J. Pointon, D. Thompson and R.M. Warren, Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS), Lancet 365 (2005), 1769-1778.
109. J.M. Lee, G.Y. Jin, S.N. Goldberg, Y.C. Lee, G.H. Chung, Y.M. Hart, S.Y. Lee and C.S. Kim, Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: Preliminary report, Radiology 230 (2004), 125-134.
110. J.S. Lee, S.Y. Kim, W.K. Hong, S.M. Lippman, J.Y. Ro, M.L. Gay and W.N. Hittelman, Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion, J Natl Cancer Inst 85 (1993), 1951-1954.
111. D. Leibovici, H.B. Grossman, C.P. Dinney, R.E. Millikan, S. Lerner, Y. Wang, J. Gu, Q. Dung and X. Wu, Polymorphisms in inflammation genes and bladder cancer: From initiation to recurrence, progression, and survival, J Clin Oncol 23 (2005), 5746-5756.
112. J. Leyton, M. Lockley, J.L. Aerts, S.K. Baird, E.O. Aboagye, N.R. Lemoine and LA. McNeish, Quantifying the activity of adenoviral E1A CR2 deletion mutants using renilla luciferase bioluminescence and 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography imaging, Cancer Res 66 (2006), 9178-9185.
113. C. Liang, K.B. Sung, R.R. Richards-Kortum and M.R. Descour, Design of a high-numerical-aperture miniature microscope objective for an endoscopic fiber confocal reflectance microscope, Appl Opt 41 (2002), 4603-4610.
114. P. Lichtenstein, N.V. Holm, P.K. Verkasalo, A. Iliadou, J. Kaprio, M. Koskenvuo, E. Pukkala, A. Skytthe and K. Hemminki, Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland, N Engl J Med 343 (2000), 78-85.
115. S.M. Lippman, J.G. Batsakis, B.B. Toth, R.S. Weber, J.J. Lee, J.W. Martin, G.L. Hays, H. Goepfert and W.K. Hong, Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis, N Engl J Med 328 (1993), 15-20.
116. A.C. Lockhart and J.D. Berlin, The epidermal growth factor receptor as a target for colorectal cancer therapy, Semin Oncol 32 (2005 , 52-60.
117. M.L. Loupart, S.A. Krause and M.S. Heck, Aberrant replication timing induces defective chromosome condensation in Drosophila ORC2 mutants, Curr Biol 10 (2000), 1547-1556.
118. C. MacAulay, P. Lane and R. Richards-Kortum, In vivo pathology: microendoscopy as a now endoscopic imaging modality, Gastrointest Endosc Clin N Am 14 (2004), 595-620, xi.
119. S. Medersbacher, M. Pedevilla, L. Vingers, M. Susani and M. Marberger, Effect of high-intensity focused ultrasound on hmnan prostate cancer in vivo, Cancer Res 55 (1995), 3346-3351.
120. C.C. Maley, P.C. Galipeau, X. Li, C.A. Sanchez, T.G. Panison, P.L. Blount and B.J. Reid, The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma, Cancer Res 64 (2004), 7629-7633.
121. C.C. Maley and B.J. Reid, Natural selection in neoplastic progression of Barrett's esophagus, Semin Cancer Biol 15 (2005), 474-483.
122. A.A. Marghoob, L.D. Swindle, C.Z. Moricz, F.A. Sanchez Negron, B. Slue, A.C. Hulpern and A.W. Kopf, Instruments and new technologies for the in vivo diagnosis of melanoma, J Am Acad Dermatol 49 (2003), 777-797; quiz 798-779.
123. M.E. Martinez, Primary prevention of colorectal cancer: Lifestyle, nutrition, exercise, Recent Results Cancer Res 166 (2005), 177-211.
124. P. Maruveda, W. Wang, P.D. Wagner and S. Srivastava, Biomarkers in molecular medicine: Cancer detection and diagnosis, Biotechniques Suppl (2005), 9-15.
125. C. Massone, A. Di Stefani and H.P. Soyer, Dermoscopy for skin cancer detection, Curr Opin Oncol 17 (2005), 147-153.
126. W.B. Mathews, C.A. Foss, D. Stoermer, H.T. Ravert, R.F. Dannals, B.R. Henke and M.G. Pomper, Synthesis and biodistribution of (11)C-GW7845, a positron-emitting agonist for peroxisome proliferator-activated receptor-gamma, J Nucl Med 46 (2005), 1719-1726.
127. S. Matoba, J.G. Kang, W.D. Patino, A. Wragg, M. Boehm, O. Gavrilova, P.J. Hurley, F. Bunz and P.M. Hwang, p53 regulates mitochondrial respiration, Science 312 (2006), 1650-1653.
128. D.M. McDonald and P.L. Choyke, Imaging of angiogenesis: From microscope to clinic, Nat Med 9 (2003), 713-725.
129. A.H. McGuire, F. Dehdashti, B.A. Siegel, A.P. Lyss, J.W. Brodack, C.J. Mathias, M.A. Mintun, J.A. Katzenellenbogen and M.J. Welch, Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma, J Nucl Med 32 (1991), 1526-1531.
130. C.C. McLaughlin, X.C. Wu, A. Jemal, H.J. Martin, L.M. Roche and V.W. Chen, Incidence of noncutaneous melanomas in the US, Cancer 103 (2005), 1000-1007.
131. T. Melo, J. Duncan, J.R. Ballinger and A.M. Rauth, BRU59-21, a second-generation 99mTc-labeled 2-nitroimidazole. for imaging hypoxia in tumors, J Nucl Med 41 (2000), 169-176.
132. D.B. Mendel, A.D. Laird, X. Xin, S.G. Louie, J.G. Christensen, G. Li, R.E. Schreck, T.J. Abrams, T.J. Ngai, L.B. Lee, LJ. Murray, J. Carver, E. Chan, K.G. Moss, J.O. Haznedar, J. Sukbuntherng, R.A. Blake, L. Sun, C. Tang, T. Miller, S. Shirazian, G. McMahon and J.M. Cherrington, In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship, Clin Cancer Res 9 (2003), 327-337.
133. E.M. Messing, T.B. Young, V.B. Hunt, K.W. Gilchrist, M.A. Newton, L.L. Brain, W.J. Hisgen, E.B. Greenberg, M.E. Kuglitsch and J.D. Wegenke, Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations, Urology 45 (1995), 387-396; discussion 396-387.
134. C.R. Meyer, T.D. Johnson, G. McLennan, D.R. Aberle, E.A. Kazerooni, H. Macmahon, B.F. Mullan, D.F. Yankelevitz, E.J. van Beek, S.G. Armato, 3rd, M.F. McNitt-Gray, A.P. Reeves, D. Gur, C.I. Henschke, E.A. Hoffman, P.H. Bland, G. Laderach, R. Pais, D. Qing, C. Piker, J. Guo, A. Starkey, D. Max, B.Y. Croft and L.P. Clarke, Evaluation of lung MD-CT nodule annotation across radiologists and methods, Acad Radiol 13 (2006), 1254-1265.
135. D. Moro-Sibilot, F. Fievet, M. Jeanmart, S. Lantuejoul, F. Arbib, M.H. Laverribre, E. Brambilla and C. Brambilla, Clinical prognostic indicators of high-grade pre-invasive bronchial lesions, Eur Respir J 24 (2004), 24-29.
136. C.D. Morris, J.P. Byrne, G.R. Armstrong and S.E. Attwood, Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation, Br J Surg 88 (2001), 1357-1362.
137. J.R. Mourant, I.J. Bigio, J. Boyer, R.L. Conn, T. Johnson and T. Shimada, Spectroscopic diagnosis of bladder cancer with elastic light scattering, Lasers Surg Med 17 (1995), 350-357.
138. B.P. Mulhall, G.R. Veerappan and J.L. Jackson, Meta-analysis: Computed tomographic colonography, Ann Intern Med 142 (2005), 635-650.
139. G. Nabi, D.R. Greene and M. O'Dohnell, How important is urinary cytology in the diagnosis of urological malignancies?, Eur Urol 43 (2003), 632-636.
140. W.G. Nelson, T.L. DeWeese and A.M. DeMarzo, The diet, prostate inflammation, and the development of prostate cancer, Cancer Metastasis Rev 21 (2002), 3-16.
141. ICA. Nyberg, R.J. Michelson, C.W. Putnam and T.A. Weinert, Toward maintaining the genome: DNA damage and replication checkpoints, Annu Rev Genet 36 (2002), 617-656.
142. M.J. O'Connell and K.A. Cimprich, G2 damage checkpoints: What is the turn-on? J Cell Sci 118 (2005), 1-6.
143. B.H. O'Neil and R.M. Goldberg, Chemotherapy for advanced colorectal cancer: Let's not forget how we got here (until we really can), Semin Oncol 32 (2005), 35-42.
144. J.A. O'Shaughnessy, G.J. Kelloff, G.B. Gordon, A.J. Dannenberg, W.K. Hong, C.J. Fabian, C.C. Sigman, M.M. Bertagnolli, S.P. Stratton, S. Lam, W.G. Nelson, F.L. Meyskens, D.S. Alberts, M. Follen, A.K. Rustgi, V. Papadimitrakopoulou, P.T. Scardino, A.F. Gazdar, L.W. Wattenberg, M.B. Sporn, W.A. Sakr, S.M. Lippman and D.D. Von Hoff, Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development, Clin Cancer Res 8 (2002 , 314-346.
145. A.J. Osborn, S.J. Elledge and L. Zou, Checking on the fork: The DNA-replication stress-response pathway, Trends Cell Biol 12 (2002), 509-516.
146. B.F. Overholt, C.J. Lightdale, K.K. Wang, M.I. Canto, S. Burdick, R.C. Haggitt, M.P. Bronner, S.L. Taylor, M.G. Grace and M. Depot Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: International, partially blinded, randomized phase III trial, Gastrointest Endosc 62 (2005), 488-498.
147. V.A. Papadimitrakopoulou, D.D. Liu, L. Mao, D.M. Shin, A. El-Naggar, H. Ibarguen, J.J. Lee, W.K. Hong and W.N. Hittelman, Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions, Cancer Epidemiol Biomarkers Prev 11 (2002), 1605-1610.
148. G. Pellacani, A.M. Cesinaro, C. Grana and S. Seidenari, In vivo confocal scanning laser microscopy of pigmented Spitz nevi: Comparison of in vivo confocal images with dermoscopy and routine histopathology, J Am Acad Dermatol 51 (2004), 371-376.
149. G. Pellacani, A.M. Cesinaro, C. Longo, C. Grana and S. Seidenari, Microscopic in vivo description of cellular architecture of dermoscopic pigment network in nevi and melanomas, Arch Dermatol 141 (2005), 147-154.
150. G. Pellacani, A.M. Cesinaro and S. Seidenari, In vivo assessment of melanocytic nests in nevi and melanomas by reflectance confocal microscopy, Mod Pathol 18 (2005), 469-474.
151. G. Pellacani, A.M. Cesinaro and S. Seidenari, In vivo confocal reflectance microscopy for the characterization of melanocytic nests and correlation with dermoscopy and histology, Br J Dermatol 152 (2005), 384-386.
152. G. Pellacani, A.M. Cesinaro and S. Seidenari, Reflectance-mode confocal microscopy for the in vivo characterization of pagetoid melanecytosis in melanomas and nevi, J Invest Dermatol 125 (2005), 532-537.
153. F. Perri, A. Piepoli, C. Bonvicini, A. Gentile, M. Quitadamo, M. Di Candia, R. Cotugno, F. Cattaneo, M.R. Zagari, L. Ricciardiello, M. Gennarelli, F. Bazzoli, G.N. Ranzani and A. Andriulli, Cytokine gene pulymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence, Cytokine 30 (2005), 293-302.
154. M.G. Pomper, J.L. Musechio, J. Zhang, U. Seheffel, Y. Zhou, J. Hilton, A. Maini, R.F. Dannals, D.F. Wong and A.P. Kozikowski, 11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase), Mol Imaging 1 (2002), 96-101.
155. M. Ponz de Leon, L. Roncucci, P. Di Donato, L. Tassi, O. Smerieri, M.G. Amorico, G. Malagoli, D. De Maria, A. Antonioli, N.J. Chahin et al., Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel, Cancer Res 48(1988), 4121-4126.
156. J.D. Potter, Colorectal cancer: Molecules and populations, J Natl Cancer Inst 91 (1999), 916-932.
157. D. Price, B. Stein, P. Sieber, R. Tutrone, J. Bailen, E. Goluboff, D. Burzon, D. Bostwiek and M. Steiner, Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: Results of a double-blind, placebo controlled, phase IIB clinical trial, J Urol 176 (2006), 965-970; discussion 970-961.
158. J. Puc, M. Keniry, H.S. Li, T.K. Pandita, A.D. Choudhury, L. Memeo, M. Mansukhani, V.V. Murty, Z. Caciong, S.E. Meek, H. Piwnica-Worms, H. Hibshoosh and R. Parsons, Lack of PTEN sequesters CHK1 and initiates genetic instability, Cancer Cell 7 (2005), 193-204.
159. J.W. Pyhtila, J.D. Boyer, K.J. Chalut and A. Wax, Fourier-domain angle-resolved low coherence interferometry through an endoscopic fiber bundle for light-scattering spectroscopy, Opt Lett 31 (2006), 772-774.
160. S.M. Rahman, Y. Shyr, P.B. Yildiz, A.L Gonzalez, H. Li, X. Zhang, P. Chaurand, K. Yanagisawa, B.S. Slovis, R.F. Miller, M. Ninan, Y.E. Miller, W.A. Franklin, R.M. Caprioli, D.P. Carbone and P.P. Massion, Proteomic patterns of preinvasive bronchial lesions, Am J Respir Crit Care Med 172 (2005), 1556-1562.
161. M. Rajadhyaksha, S. Gonzalez and J.M. Zavislan, Detectability of contrast agents for confocal reflectance imaging of skin and microcirculation, J Biomed Opt 9 (2004), 323-331.
162. D.F. Ransohoff, Colon cancer screening in 2005: Status and challenges, Gastroenterology 128 (2005), 1685-1695.
163. B.J. Reid, P.L. Blount, Z. Feng and D.S. Levine, Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia, Am J Gastroenterol 95 (2000), 3089-3096.
164. B.J. Reid, D.S. Levine, G. Longton, P.L. Blount and P.S. Rabinovitch, Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets, Am J Gastroenterol 95 (2000), 1669-1676.
165. E. Reszka and W. Wasowicz, Genetic polymorphism of N-acetyltransferase and glutathione S-transferase related to neoplasm of genitourinary system. Minireview, Neoplasma 49 (2002), 209-216.
166. M.P. Rosin, X. Cheng, C. Poh, W.L. Lam, Y. Huang, J. Lovas, K. Berean, J.B. Epstein, R. Priddy, N.D. Le and L. Zhang, Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia, Clin Cancer Res 6 (2000), 357-362.
167. M.P. Rosin, W.L. Lam, C. Poh, N.D. Le, R.J. Li, T. Zeng, R. Priddy and L. Zhang, 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites, Cancer Res 62 (2002), 6447-6450.
168. H.K. Roy, Y.L. Kim, Y. Liu, R.K. Wali, M.J. Goldberg, V. Turzhitsky, J. Horwitz and V. Backman, Risk stratification of colon carcinogenesis through enhanced backscattering spectroscopy analysis of the uninvolved colonic mucusa, Clin Cancer Res 12 (2006), 961-968.
169. H.K. Roy, Y. Liu, R.K. Wali, Y.L. Kim, A.K. Kromine, M.J. Goldberg and V. Backman, Four-dimensional elastic light-scattering fingerprints as preneoplastic markers in the rat model of colon carcinogenesis, Gastroenterology 126 (2004), 1071-1081; discussion 1948.
170. Y. Satoh, Y. Ishikawa, K. Nakagawa, T. Hirano and E. Tsuchiya, A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers, Br J Cancer 75 (1997), 678-683.
171. J. Schmidbauer, F. Witjes, N. Schmeller, R. Donat, M. Susani and M. Marberger, Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy, J Urol 171 (2004), 135-138.
172. M.D. Schnall, J. Blume, D.A. Bluemke, G.A. Deangelis, N. Debruhl, S. Harms, S.H. Heywang-Kobrunner, N. Hylton, C.K. Kahl, E.D. Pisano, P. Causer, S.J. Schnitt, S.F. Smazal, C.B. Stelling, C. Lehman, P.T. Weatherall and C.A. Gatsonis, MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883, J Surg.Oncol 92 (2005), 32-38.
173. T.G. Schnell, S.J. Sontag, G. Chejfec, G. Aranha, A. Metz, S. O'Connell, U.J. Seidel and A. Soonenberg, Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia, Gastroenterology 120 (2001), 1607-1619.
174. Y. Schwarz, J. Greif, H.D. Becker, A. Ernst and A. Mehta, Real-time electromagnetic navigation bronchoscopy to peripheral lung lesions using overlaid CT images: The first human study, Chest 129 (2006 , 988-994.
175. I.A. Scotiniotis, M.L. Kochman, J.D. Lewis, E.E. Furth, E.F. Rosato and G.G. Ginsberg, Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma, Gastrointest Endosc 54 (2001), 689-696.
176. K. Shah and R. Weissleder, Molecular optical imaging: Applications leading to the development of present day therapeutics, NeuroRx 2 (2005), 215-225.
177. P. Sharma, A. Bansal, S. Mathur, S. Wani, R. Cherian, D. McGregor, A. Higbee, S. Hall and A. Weston, The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus, Gastrointest Endosc 64 (2006), 167-175.
178. P. Sharma, B.F. Kimler, J.L. Clark, T.L. Metheny, C.M. Zalles, M. Hall and C.J. Fabian, ER-alpha expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and abnormal cytomorphology, Proc Amer Assoc Cancer Res 46 (2005).
179. P. Sharma, A.P. Weston, M. Topalovski, R. Cherian, A. Bhattacharyya and R.E. Sampliner, Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus, Gut 52 (2003), 24-27.
180. L.M. Siegel, P.D. Stevens, C.J. Lightdale, P.H. Green, S. Goodman, R.J. Garcia-Carrasquillo and H. Rotterdam, Combined magnification endoscopy with chromoendoscopy in the evaluation of patients with suspected malabsorption, Gastrointest Endosc 46 (1997), 226-230.
181. M.K. Simick and L. Lilge, Optical transillumination spectroscopy to quantify parenchymal tissue density: An indicator for breast cancer risk, Br J Radiol 78 (2005), 1009-1017.
182. S.J. Skates, F.J. Xu, Y.H. Yu, K. Sjovall, N. Einhorn, Y. Chang, R.C. Bast, Jr. and R.C. Knapp, Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers, Cancer 76 (1995 , 2004-2010.
183. M.L. Slattery and R.A. Kerber, Family history of cancer and colon cancer risk: The Utah Population Database, J Natl Cancer Inst 86 (1994), 1618-1626.
184. M.L. Slattery, T.R. Levin, K. Ma, D. Goldgar, R. Holubkov and S. Edwards, Family history and colorectal cancer: Predictors of risk, Cancer Causes Control 14 (2003), 879-887.
185. M.L. Slattery, J.D. Potter, D.M. Duncan and T.D. Berry, Dietary fats and colon cancer: Assessment of risk associated with specific fatty acids, Int J Cancer 73 (1997), 670-677.
186. M.L. Slattery, J.D. Potter and A.W. Sorenson, Age and risk factors for colon cancer (United States and Australia): Are there implications for understanding differences in case-control and cohort studies? Cancer Causes Control 5 (1994), 557-563.
187. D.B. Sedee, R. Conant, M. Chalfant, S. Miron, E. Klein, R. Bahnson, J.P. Spirnak, B. Carlin, E.M. Bellon and B. Rogers, Preliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer, Clin Nucl Med 21 (1996), 759-767.
188. K. Sokolov, J. Aaron, B. Hsu, D. Nida, A. Gillenwater, M. Follen, C. MacAulay, K. Adler-Storthz, B. Korgel, M. Descour, R. Pasqualini, W. Arap, W. Lam and R. Richards-Kortum, Optical systems for in vivo molecular imaging of cancer, Technol Cancer Res Treat 2 (2003), 491-504.
189. M.B. Sporn and K.T. Liby, Cancer chemoprevention: Scientific promise, clinical uncertainty, Nat Clin Pract Oncol 2 (2005), 518-525.
190. M.S. Steiner and C.R. Pound, Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia, Clin Prostate Cancer 2 (2003), 24-31.
191. M. Stoeckli, P. Chaurand, D.E. Hallahan and R.M. Caprioli, Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues, Nat Med 7 (2001), 493-496.
192. T. Stratmann and A.S. Kang, Cognate peptide-receptor ligand mapping by directed phage display, Proteome Sci 3 (2005), 7.
193. S.P. Stratton, Prevention of non-melanoma skin cancer, Curr Oncol Rep 3 (2001), 295-300.
194. N. Subhas, P.V. Patel, H.K. Pannu, H.A. Jacene, E.K. Fishman and R.L. Wahl, Imaging of pelvic malignancies with in-line FDG PET-CT: Case examples and common pitfalls of FDG PET, Radiographics 25 (2005), 1031-1043.
195. R.D. Suh, A.B. Wallace, R.E. Sheehan, S.B. Heinze and J.G. Goldin, Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablalion-preliminary results, Radiology 229 (2003), 821-829.
196. D.C. Sullivan and G. Kelloff, Seeing into cells. The promise of in vivo molecular imaging in oncology, EMBO Rep 6 (2005), 292-296.
197. W. Sun and D.G. Haller, Adjuvant therapy of colon cancer, Semin Oncol 32 (2005), 95-102.
198. S.M. Swetter, B.L. Waddell, M.D. Vazquez and V.S. Khosravi, Increased effectiveness of targeted skin cancer screening in the Veterans Affairs population of Northern California, Prev Med 36 (2003), 164-171.
199. T. Takayama, S. Katsuki, Y. Takahashi, M. Ohi, S. Nojiri, S. Sakamaki, J. Kato, K. Kogawa, H. Miyake and Y. Niitsu, Aberrant crypt feel of the colon as precursors of adenoma and cancer, N Engl J Med 339 (1998), 1277-1284.
200. Z.S. Tannous, M.C. Mihm, T.J. Flotte and S. Gonzalez, In vivo examination of lentigo maligna and malignant melanoma in situ, lentigo maligna type by near-infrared reflectance confocal microscopy: comparison of in vivo confocal images with histologic sections, J Am Acad Dermatol 46 (2002), 260-263.
201. R. Tatlidil, H. Jadvar, J.R. Bading and P.S. Conti, Incidental colonic fluorodeoxyglucose uptake: Correlation with colonoscopic and histopathologic findings, Radiology 224 (2002), 783-787.
202. L. Teixeira da Costa and C. Lengauer, Exploring and exploiting instability, Cancer Biol Ther 1 (2002), 212-225.
203. C.M. Tempany, E.A. Stewart, N. McDannold, B.J. Quade, F.A. Jolesz and K. Hynynen, MR imaging-guided focused ultrasound surgery of uterine leiomyomas: A feasibility study, Radiology 226 (2003), 897-905.
204. I.M. Thompson, P.J. Goodman, C.M. Tangen, M.S. Lucia, G.J. Miller, L.G. Ford, M.M. Lieber, R.D. Cespedes, J.N. Atkins, S.M. Lippman, S.M. Carlin, A. Ryan, C.M. Szczepanek, J.J. Crowley and C.A. Coltman, Jr., The influence of finasteride on the development of prostate cancer, N Engl J Med 349 (2003), 215-224.
205. J.A. Tice, S.R. Cummings, E. Ziv and K. Kerlikowske, Mammographic breast density and the gail model for breast cancer risk prediction in a screening population, Breast Cancer Res Treat 94 (2005), 115-122.
206. M. Tsubul, A. Hayashi, N. Ikeda, H. Honda, Y. Kato, S. Ichinose and H. Kato, Optical coherence tomography in the diagnosis of bronchial lesions, Lung Cancer 49 (2005), 387-394.
207. T. Uchida, N.T. Sanghvi, T.A. Gardner, M.O. Koch, D. Ishii, S. Minei, T. Satoh, T. Hyedo, A. Irie and S. Baba, Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: A preliminary report, Urology 59 (2002), 394-398; discussion 398-399.
208. A. Unterhuber, B. Povazay, K. Bizheva, B. Hermann, H. Sattmann, A. Stingl, T. Le, M. Seefeld, R. Menzet, M. Preusser, H. Budka, C. Schubert, H. Reitsamer, P.K. Ahnelt, J.E. Morgan, A. Cowey and W. Drexler, Advances in broad bandwidth light sources for ultrahigh resolution optical coherence tomography, Phys Med Biol 49 (2004), 1235-1246.
209. A. Urisman, RJ. Molinaro, N. Fischer, S.J. Plummer, G. Casey, E.A. Klein, K. Malathi, C. Magi-Galluzzi, R.R. Tubbs, D. Ganem, R.H. Silverman and J.L. Derisi, Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant, PLoS Pathog 2 (2006), 025.
210. J.S. van den Brink, Y. Watanabe, C.K. Kuhl, T. Chung, R. Muthnpillai, M. Van Cauteren, K. Yamada, S. Dymarkowski, J. Bogaert, J.H. Maki, C. Matos, J.W. Casselman and R.M. Hoogeveen, Implications of SENSE MR in routine clinical practice, Eur J Radial 46 (2003), 3-27.
211. M.C. van Konwen, J.P. Drenth, J.H. van Krieken, H. van Goor, P. Friederich, W.J. Oyan and F.M. Nagengast, Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management, Eur J Nucl Meal Mol Imaging 33 (2006), 270-274.
212. J.R. van Nagell, Jr., P.D. DePriest, M.B. Reedy, H.H. Gallion, F.R. Ueland, E.J. Pavlik and R.J. Kryscio, The efficacy of transvaginal sonograpbie screening in asymptomatic women at risk for ovarian cancer, Gynecol Oncol 77 (2000), 350-356.
213. P. Veit, C. Kuhle, T. Beyer, H. Kuehl, C.U. Herborn, G. Borsch, H. Stergar, J. Barkhansen, A. Bockisch and G. Antoch, Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: Technical feasibility and first experiences in patients with colorectal cancer, Gut 55 (2006), 68-73.
214. R.W. Veltri, A.W. Partin and M.C. Miller, Quantitative Nuclear Grade (QNG): The clinical applications of the quantitative measurement of nuclear structure using image analysis, (Vol. 2), G.J. Kelloff, E.T. Hawk and C.C. Sigman, eds, Totowa, NJ, Humana Press, 2005, pp. 97-108.
215. B.J. Venmans, T.J. van Boxem, E.F. Smit, P.E. Postmus and T.G. Sutedja, Outcome of bronchial carcinoma in situ, Chest 117 (2000), 1572-1576.
216. T.J. Vogl, R. Straub, T. Lehnert, K. Eichler, T. Luder-Luhr, J. Peters, S. Zangos, O. Sollner and M. Mack, Percutaneous thermoablation of pulmonary metastases. Experience with the application of laser-induced thermotherapy (LITT) and radiofrequency ablation (RFA), and a literature review, Rofo 176 (2004), 1658-1666.
217. Y. Wang, Y. Zhao, J.S. Nelson, Z. Chen and R.S. Windeler, Ultrahigh-resolution optical coherence tomography by broadband continuum generation from a photonic crystal fiber, Opt Lett 28 (2003), 182-184.
218. E. Warner, D.B. Plewes, R.S. Shumak, G.C. Catzavelos, L.S. Di Prospero, M.J. Yaffe, V. Goel, E. Ramsay, P.L. Chart, D.E. Cole, G.A. Taylor, M. Cutrara, T.H. Samuels, J.P. Murphy, J.M. Murphy and S.A. Narod, Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer, J Clin Oncol 19 (2001), 3524-3531.
219. T. Watanabe, T.T. Wu, P.J. Catalano, T. Ueki, R. Satriano, D.G. Haller, A.B. Benson, 3rd and S.R. Hamilton, Molecular predictors of survival after adjuvant chemotherapy for colon cancer, N Engl J Med 344 (2001), 1196-1206.
220. A. Wax, C. Yang, V. Backman, K. Badizadegan, C.W. Boone, R.R. Dasari and M.S. Feld, Cellular organization and substructure measured using angle-resolved low-coherence interferometry, Biophys J 82 (2002), 2256-2264.
221. A. Wax, C. Yang, M.G. Muller, R. Nines, C.W. Boone, V.E. Steele, G.D. Stoner, R.R. Dasari and M.S. Feld, In situ detection of neoplastic transformation and chemopreventive effects in rat esophagus epithelium using angle-resolved low-coherence interferometry, Cancer Res 63 (2003), 3556-3559.
222. S.R. Wedge, D.J. Ogilvie, M. Dukes, J. Kendrew, R. Chester, J.A. Jackson, S.J. Boffey, P.J. Valentine, J.O. Curwen, H.L. Musgrove, G.A. Graham, G.D. Hughes, A.P. Thomas, E.S. Stokes, B. Curry, G.H. Richmond, P.F. Wadsworth, A.L. Bigley and L.F. Hennequin, ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration, Cancer Res 62 (2002), 4645-4655.
223. S.M. Wilhelm, C. Carter, L. Tang, D. Wilkie, A. McNabola, H. Rong, C. Chen, X. Zhang, P. Vincent, M. McHugh, Y. Cao, J. Shujath, S. Gawlak, D. Eveleigh, B. Rowley, L. Liu, L. Adnane, M. Lynch, D. Auclair, I. Taylor, R. Gedrich, A. Voznesensky, B. Riedl, L.E. Post, G. Bollag and P.A. Trail, BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis, Cancer Res 64 (2004 , 7099-7109.
224. S. Wilkinson and G. Chodak, The role of 111indium-capromab pendetide imaging for assessing biochemical failure after radical prostatectomy, J Urol 172 (2004), 133-136.
225. M.R. Wrensch, N.L. Petrakis, R. Miike, E.B. King, K. Chew, J. Neuhaus, M.M. Lee and M. Rhys, Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid, J Natl Cancer Inst 93 (2001), 1791-1798.
226. K. Yanagisawa, Y. Shyr, B.J. Xu, P.P. Massion, P.H. Larsen, B.C. White, J.R. Roberts, M. Edgerton, A. Gonzalez, S. Nadaf, J.H. Moore, R.M. Caprioli and D.P. Carbone, Proteomic patterns of tumour subsets in non-small-cell lung cancer, Lancet 362 (2003), 433-439.
227. S. Yasada, H. Fujii, T. Nakahara, N. Nishiumi, W. Takahashi, M. Ide and A. Shuhtsu, 18F-FDG PET detection of colonic adenomas, J Nucl Med 42 (2001), 989-992.
228. G.P. Young, D.J. St John, S.J. Winawer and P. Rozen, Choice of fecal occult blood tests for colorectal cancer screening: Recommendations based on performance characteristics in population studies: A WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report, Am J Gastroenterol 97 (2002), 2499-2507.
229. Y. Zhang, J. Laterra and M.G. Pomper, Imaging modulation of hedgehog signaling in vivo, Society of Molecular Imaging Annual Meeting (2005), Abst. No. 295.
230. J. Zhou, J.H. Neale, M.G. Pomper and A.P. Kozikowski, NAAG peptidase inhibitors and their potential for diagnosis and therapy, Nat Rev Drug Discov 4 (2005), 1015-1026.